A majority-owned operating subsidiary of NRS Health & Wellness GP LLC (“NRS”), miR Scientific, LLC (miR) is a precision molecular bioscience company that has developed proprietary, non-invasive liquid biopsy urine tests to definitively detect prostate and bladder cancers.
miR Scientific’s platform has the ability to distinguish between aggressive and indolent prostate and bladder tumors prior to potentially life-changing interventions. The Company creates and delivers scalable breakthrough technologies for the provision of accessible diagnostic, prognostic, monitoring and companion products and services for large at-risk cancer populations, thereby revolutionizing cancer management.
miR Scientific’s powerful and accurate platform technology can have a profound impact on reducing deaths and adverse side effects such as additional medical procedures, impairment to quality-of-life and cost-of-care for bladder and prostate cancer patients.
The Company classifies and profiles RNA entities to provide an unprecedented level of accuracy which, together with its low cost and ease of administration, positions its Disease Management Platform™ to become the next-generation global standard of care for the early detection of prostate and bladder cancers.
NRS Health & Wellness GP LLC (NRS) is a subsidiary of New Reality Solutions, an innovations company at the forefront of science and technology. Working with leading, interdisciplinary scientists, the Company deploys cutting edge precision molecular biology tools with proprietary and novel statistical prediction algorithms to create and commercialize visionary integrated solutions to critical global challenges in health, wellness and sustainable development. We call it Convergence Innovation™. Since inception, the Company has had breakthrough developments in its Healthcare and in its Agriculture/Sustainable Resource Management business verticals, which are on a rapid path to commercialization. NRS has formed several strategic partnerships with prominent research institutions globally, including Israel’s renowned Agricultural Research Organization (ARO, also known as the Volcani Center) and the State University of New York (SUNY) Center for Excellence in Cancer Genomics.